Abrysvo (RSV vaccine) is a bivalent vaccine used to lower the risk of illness caused by respiratory syncytial virus (RSV). It's FDA-approved for adults ages 60 years and older, and adults who are between 32 and 36 weeks of pregnancy to protect babies during the first 6 months of life. Abrysvo (RSV vaccine) is given as an injection into the muscle and can cause tiredness, headache, and pain at the injection site as side effects.
Prevention of respiratory syncytial virus (RSV) in:
Adults ages 60 years and older
Pregnant females between 32 to 36 weeks of pregnancy
Abrysvo (RSV vaccine) is a recombinant protein subunit vaccine, meaning pieces of the virus are made and put into the vaccine. It helps protect you from respiratory syncytial virus (RSV) infection by triggering your immune system to make proteins called antibodies against the virus. These antibodies will help prevent infection by attacking the virus if it ever infects your body.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Lowers risk of RSV-related illness by up to 86% in people 60 years and older
Given as a single dose
Offers protection against RSV-A and RSV-B, two types of the virus
Injection might be uncomfortable
Not approved for people under 60 years old unless you're pregnant
Can cause tiredness and headache as side effects
Before getting Abrysvo (RSV vaccine), discuss your full medical history with your provider. If you have conditions (or are taking medications) that weaken your immune system, this vaccine might not work as well for you.
Injectable vaccines like Abrysvo (RSV vaccine) can sometimes cause fainting. After getting the vaccine, stay seated for a few minutes and make sure you don't feel dizzy or faint when carefully standing up.
Abrysvo (RSV vaccine) isn't made with latex and doesn't contain preservatives. However, you should tell your provider all of your allergies before getting Abrysvo (RSV vaccine) so they can make sure it's safe for you.
Share a list of your previous vaccinations with your provider, so they can make sure you're up to date with all of your vaccines.
Abrysvo (RSV vaccine) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
A higher amount of preterm (early) births were observed in pregnant females who got Abrysvo (RSV vaccine) compared to those who didn't during clinical studies. It's not clear if this was due to the vaccine, or another cause. To lower the potential risk of this happening, your provider will administer Abrysvo (RSV vaccine) between 32 and 36 weeks of your pregnancy.
Although rare, it's possible for Abrysvo (RSV vaccine) to cause a severe allergic reaction. Get medical help right away if you experience skin rash, tightness in your chest, trouble breathing, or swelling in your lips, tongue, throat, or face after receiving Abrysvo (RSV vaccine).
Injectable vaccines like Abrysvo (RSV vaccine) can cause some people to feel faint afterwards. Stay seated for a while after getting your vaccine, and stand up slowly to make sure you don't fall if you feel faint or dizzy.
Risk factors: Medical conditions that weaken the immune system | Taking medications that weaken your immune system
Abrysvo (RSV vaccine) might not work as well in people with a weakened immune system. If you have any medical conditions (e.g., human immunodeficiency virus or HIV, cancer) or take medications that weaken your immune system (e.g., high-dose corticosteroids, transplant medications, cancer medications), talk to your provider first before getting Abrysvo (RSV vaccine).
Dosage | Quantity | Price as low as | Price per unit |
---|---|---|---|
1 dose | 1 kit | $313.89 | $313.89 |
The typical dose is 0.5 mL injected into the muscle by a healthcare provider.
Prevention of respiratory syncytial virus (RSV) in:
Adults ages 60 years and older
Pregnant females between 32 to 36 weeks of pregnancy
Prevention of illness caused by respiratory syncytial virus (RSV)
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Centers for Disease Control and Prevention. (2020). Fainting (Syncope) after Vaccination.
Centers for Disease Control and Prevention. (2022). People at high risk for severe RSV infection.
Centers for Disease Control and Prevention. (2023). Healthcare providers: RSV vaccination for pregnant people.
Centers for Disease Control and Prevention. (2023). Immunization Schedules.
Centers for Disease Control and Prevention. (2023). Respiratory syncytial virus (RSV) vaccine VIS.
Centers for Disease Control and Prevention. (2024). Frequently asked questions about RSV vaccine for adults.
Centers for Disease Control and Prevention. (2024). RSV prevention.
Immunize.org. (2024). Vaccine Recommendations During Pregnancy. Ask the Experts: RSV (Respiratory Syncytial Virus).
Pfizer Inc. (2023). Find Pfizer's RSV vaccine near you and make your appointment today.
Pfizer Inc. (2023). U.S. FDA approves ABRYSVO™, Pfizer’s vaccine for the prevention of respiratory syncytial virus (RSV) in older adults. Business Wire.
Pfizer Laboratories Div Pfizer Inc. (2023). Abrysvo- respiratory syncytial virus vaccine kit [package insert]. DailyMed.
World Health Organization. (2020). How do vaccines work?
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.